Privigen 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DR26FFBM3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,908
Award facts
- Contract value 100% obligated
- $34,908.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $34,908 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Privigen 10% Vial 200ML. This delivery order, issued on November 20, 2025, with an ultimate completion date of December 12, 2025, operates under a firm fixed-price structure with no set-aside designation. The award represents a continuation of DMS Pharmaceutical Group's role as a critical pharmaceutical supplier within the Department of Defense's medical supply chain, leveraging the company's established capabilities in distributing a comprehensive range of pharmaceutical products to federal agencies.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a contract awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V program represents part of the broader $30.3 billion acquisition strategy designed to provide DoD military healthcare facilities worldwide with diverse pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group's demonstrated performance across multiple delivery orders positions it as a key regional prime vendor contractor supporting the Department of Defense's global healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FFBM3?
SPE2DR26FFBM3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FFBM3 worth?
The government has obligated $34,908 on SPE2DR26FFBM3.
Is contract SPE2DR26FFBM3 an order under another contract?
Yes. SPE2DR26FFBM3 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBM3 competed?
The extent of competition for SPE2DR26FFBM3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award